Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-432729
Filing Date
2013-11-07
Accepted
2013-11-07 15:50:51
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d590446d10q.htm 10-Q 473220
2 EX-31.1 d590446dex311.htm EX-31.1 7360
3 EX-31.2 d590446dex312.htm EX-31.2 7455
4 EX-32.1 d590446dex321.htm EX-32.1 3713
5 EX-32.2 d590446dex322.htm EX-32.2 3809
  Complete submission text file 0001193125-13-432729.txt   3718590

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT infi-20130930.xml EX-101.INS 428790
7 XBRL TAXONOMY EXTENSION SCHEMA infi-20130930.xsd EX-101.SCH 46516
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE infi-20130930_cal.xml EX-101.CAL 57788
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE infi-20130930_def.xml EX-101.DEF 219577
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE infi-20130930_lab.xml EX-101.LAB 336252
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE infi-20130930_pre.xml EX-101.PRE 255440
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 131200471
SIC: 2834 Pharmaceutical Preparations